The use of cetuximab in the treatment of metastatic colorectal cancer is limited by development of resistance.
Maintenance Treatment with Cetuximab and BAY86-9766 Increases Antitumor Efficacy of Irinotecan plus Cetuximab in Human Colorectal Cancer Xenograft Models
TROIANI, Teresa;Napolitano, Stefania;Martini, Giulia;MARTINELLI, Erika;MORGILLO, Floriana;CIARDIELLO, Fortunato
2015
Abstract
The use of cetuximab in the treatment of metastatic colorectal cancer is limited by development of resistance.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
